For instance, several members of the nuclear factor- (NF-) κB signaling pathway work cooperatively to trigger an immune response in MG [13], and a recent study found that miR-155 was upregulated in MG patients, while suppressing miR-155 impaired NF-κB signaling [14]. This evidence concerns the gene NFKB1 and myasthenia gravis.